Search
Close this search box.
I want to

Contacts and Support

Collaborative Mentorship Networks for Chronic Pain and Addiction

  • Connects family physicians with colleagues who have experience and expertise treating pain and addiction
  • Provides an environment to establish long term, trusted professional relationships in a community of practice
  • Visit www.cmnalberta.com for more information and to join

OUD – Telephone Consultation

  • Telephone consult service is for primary care physicians and prescribers seeking advice regarding:
    • Initiating and managing opioid agonist therapy
    • Prescribing drugs like buprenorphine/naloxone, methadone or naloxone
    • Treating patients with existing opioid use disorder
    • Managing opioid withdrawal and consideration of opioid agonist therapy
  • 7 days per week, 08:00-17:00
    • NORTH of Red Deer — call 1-800-282-9911 or 1-780-735-0811
    • SOUTH of Red Deer — call 1-800-661-1700 or 403-944-4486

Virtual Opioid Dependency Program

  • Technology delivered same day medication starts, opioid treatment transition service, ongoing opioid dependency care
  • 7 days per week, 08:00-20:00
  • Toll Free: 1-844-383-7688

E-Referral Advice Request

    • Non-urgent advice answered by a specialist within five calendar days through Alberta Netcare.
    • For a list of current specialties accepting eReferral Advice Requests across Alberta, go online.

OAT Gap Coverage Program

Effective April 1, 2020, the Government of Alberta will enhance access to Opioid Agonist Therapy (OAT) through the establishment of an OAT Gap Coverage Program that will provide Albertans who currently do not have supplementary health benefits coverage with no-cost coverage for 120 days of buprenorphine/naloxone or methadone.

To be eligible for the Alberta OAT Gap Coverage Program at no cost to the individual, patients must

  • not have other supplementary health benefits,
  • be registered with the Alberta Health Care Insurance Plan and have a valid Personal Health Number (PHN); pseudo PHNs are not eligible under this program, and
  • have a valid prescription for buprenorphine/naloxone or methadone.


The program will provide 120 days of the prescribed therapy. Participants in the program are expected to enroll in a supplementary health program for continuing coverage of their OAT needs. Information on how to enroll in government-sponsored supplementary health benefit programs is publicly available on the Alberta Health website.